The peptide excels at accelerating natural healing processes but cannot regenerate tissue that the body cannot rebuild on its own
At low weekly doses, the 28-day reconstituted-use window is the practical cap reconstitute in halves if dosing slower than 2.5 mg/week
Serum B12 reference ranges vary between laboratories, but generally, levels below 148 pmol/L are considered deficient, whilst levels between 148258 pmol/L are regarded as borderline and may warrant further investigation or a trial of treatment, particularly if symptoms are present
What is happening this July is that the agency has reopened the question and convened its advisory committee to weigh whether BPC-157, along with six other nominated peptide-related bulk substances, should be added to the 503A bulks list
Mechanistic Novelty Dihexa and Cerebrolysin are not direct competitors they occupy entirely different tiers of the evidence hierarchy, and comparing them reveals more about the drug development process than about relative efficacy
